Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference

Bioventus (Nasdaq: BVS) announced that CEO Rob Claypoole will present at the 44th Annual J.P.

Rhea-AI Summary

Bioventus (Nasdaq: BVS) announced that CEO Rob Claypoole will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 at 9:45 a.m. PT / 12:45 p.m. ET.

The presentation will be available via live webcast on the company's Investors website and will be available for replay through February 14, 2026. The webcast will include a Q&A session.

Argus Jan 6 session

+1.06% close to close Open Argus

Details

News Market Reaction – BVS

On Jan 6, the day this news came out, BVS closed 1.06% above the previous close.

Data tracked by StockTitan Argus for the Jan 6 session.

Market Context

This announcement highlights Bioventus’ upcoming presentation at the 44th Annual J.P. Morgan Healthc...

Analysis

This announcement highlights Bioventus’ upcoming presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026, with a webcast and replay available through February 14, 2026. Historically, conference notices for Bioventus have had smaller market impact than earnings releases, which previously moved the stock more sharply. Investors may focus on any new details shared at the conference regarding growth, margins, or capital structure beyond this scheduling update.

Key Figures

Conference edition: 44th Annual Presentation date: January 14, 2026 Presentation time PT: 9:45 a.m. PT +2 more

Conference edition

44th Annual

J.P. Morgan Healthcare Conference

Presentation date

January 14, 2026

J.P. Morgan Healthcare Conference slot

Presentation time PT

9:45 a.m. PT

Scheduled presentation start time

Presentation time ET

12:45 p.m. ET

Corresponding Eastern Time

Webcast replay end

February 14, 2026

Replay availability on Investors website

Historical Context

5 past events · Latest: Nov 25

5 events

1. Nov 25

   Conference presentation

   24h Move

   +5.1%

   Piper Sandler healthcare conference presentation and webcast details.

2. Nov 04

   Earnings results

   24h Move

   +15.1%

   Q3 2025 results with higher EPS and adjusted EBITDA growth.

3. Oct 28

   Earnings date notice

   24h Move

   +3.4%

   Announcement of Q3 2025 earnings release date and call details.

4. Sep 03

   Conference participation

   24h Move

   -2.5%

   Morgan Stanley global healthcare conference fireside chat announcement.

5. Aug 07

   Conference participation

   24h Move

   -0.1%

   Canaccord Genuity growth conference presentation and webcast information.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DURHAM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Chief Executive Officer, will present at the 44^th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 9:45 a.m. PT (12:45 p.m. ET).

The live webcast of the presentation, including Q&A, may be accessed on the Investors section of the Bioventus website and will be available for replay until February 14, 2026.

About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and X. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

Investor and Media Inquiries:
Dave Crawford
919-474-6787
dave.crawford@bioventus.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Bioventus (BVS) present at the J.P. Morgan Healthcare Conference?

Bioventus CEO Rob Claypoole will present on January 14, 2026 at 9:45 a.m. PT / 12:45 p.m. ET.

How can investors watch the Bioventus (BVS) presentation on January 14, 2026?

Investors can watch the live webcast on the Investors section of the Bioventus website.

Will the Bioventus (BVS) J.P. Morgan presentation be available after the event?

Yes, the replay will be available on the company's Investors website through February 14, 2026.

Who is presenting for Bioventus (BVS) at the 44th Annual J.P. Morgan Healthcare Conference?

The presenter is Rob Claypoole, Chief Executive Officer of Bioventus.

Will there be a Q&A during the Bioventus (BVS) webcast on January 14, 2026?

Yes, the live webcast will include a Q&A session.